Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Increased glycolytic metabolism recently emerged as an essential process driving host defense against Mycobacterium tuberculosis (Mtb), but little is known about how this process is regulated during infection. Here, we observe repression of host glycolysis in Mtb-infected macrophages, which is dependent on sustained upregulation of anti-inflammatory microRNA-21 (miR-21) by proliferating mycobacteria. The dampening of glycolysis by miR-21 is mediated through targeting of phosphofructokinase muscle (PFK-M) isoform at the committed step of glycolysis, which facilitates bacterial growth by limiting pro-inflammatory mediators, chiefly interleukin-1β (IL-1β). Unlike other glycolytic genes, PFK-M expression and activity is repressed during Mtb infection through miR-21-mediated regulation, while other less-active isoenzymes dominate. Notably, interferon-γ (IFN-γ), which drives Mtb host defense, inhibits miR-21 expression, forcing an isoenzyme switch in the PFK complex, augmenting PFK-M expression and macrophage glycolysis. These findings place the targeting of PFK-M by miR-21 as a key node controlling macrophage immunometabolic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationWidespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“We thus examined protein expression, which miRNAs preferentially regulate (Selbach et al., 2008) and found that miR-21 overexpression dosedependently reduced basal PFK-m protein levels in RAW267.”
BackgroundOtto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427 · cited 1×
“Therefore, it is clear that the reprogramming of central energy metabolism observed during Mtb infection is distinct from the traditional ‘‘Warburg effect’’ observed in LPS-stimulated macrophages or tumor cells (Koppenol et al., 2011), with increased glycolytic rates being a key feature of infected macrophages.”
BackgroundJha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
Metabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692 · cited 1×
“Reprogramming of cellular metabolism has emerged as a directive mechanism controlling responses in immune cells (Pearce and Pearce, 2013).”
BackgroundPalsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397 · cited 10×
“Consistent with this, IFN-g-driven HIF-1a and nitric oxide (NO) production have emerged as key processes sensitive to changes in glycolysis (Braverman et al., 2016; Braverman and Stanley, 2017) that miR-21 also impact.”
BackgroundInfluentialSelf-citationEverts, B., Amiel, E., Huang, S. C.-C., Smith, A. M., Chang, C.-H., Lam, W. Y., Redmann, V., Freitas, T. C., Blagih, J., van der Windt, G. J. W., et al. (2014) · Nature Immunology · doi:10.1038/ni.2833 · Cited by 1,064 · cited 1×
“, 2013), antigen presentation (Everts et al., 2014), and containment of bacteria (Garaude et al.”
BackgroundSheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005 · cited 15×
“We previously demonstrated that miR-21 is induced by TLR4 signaling to promote interleukin-10 (IL-10) production by limiting PDCD4 protein (Sheedy et al., 2010), and other groups have implicated this in efferocytosis, alongside negative regulation of tumor necrosis factor (TNF) by targetingPTENprotein (Das et al.”
BackgroundResultInfluentialSelf-citationHu, X., & Ivashkiv, L. B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.002 · Cited by 928 · cited 1×
“Although IFN-g alters transcription of target genes (Hu and Ivashkiv, 2009), we did not observe alterations in pri-miR-21 transcript levels in IFN-g-primed BMDMs after 24-h LPS treatment or infection with Mtb H37Ra (Figure 7E).”
BackgroundMartin, B., Hirota, K., Cua, D. J., Stockinger, B., & Veldhoen, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.020 · Cited by 822
Cited by
Metabolic reprogramming in macrophage responses
Liu, Y., Xu, R., Gu, H., Zhang, E., Qu, J., Cao, W., Huang, X., Yan, H., He, J., & Cai, Z. (2021) · Biomarker Research · doi:10.1186/s40364-020-00251-y · Cited by 641
Tribbles1 is host protective during in vivo mycobacterial infection
Hammond, F. R., Lewis, A., Pollara, G., Tomlinson, G. S., Noursadeghi, M., Kiss-Toth, E., & Elks, P. M. (2024) · eLife · doi:10.7554/elife.95980 · Cited by 2
Metadata
- Authors
- Hackett, E. E., Charles-Messance, H., O’Leary, S. M., Gleeson, L. E., Muñoz-Wolf, N., Case, S., Wedderburn, A., Johnston, D. G. W., Williams, M. A., Smyth, A., Ouimet, M., Moore, K. J., Lavelle, E. C., Corr, S. C., Gordon, S. V., Keane, J., & Sheedy, F. J.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 30
- Issue
- 1
- Pages
- 124-136.e4
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2999345237
- Cited by
- 173
- References
- 18
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.